ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,452Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 807

$543K Total Retail Price of All Prescriptions

Rank: 91 out of 807

522 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 522 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 522 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 7,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 494 463 1 2
SIMVASTATIN 417 404 2 1
AMLODIPINE BESYLATE 370 343 3 5
METOPROLOL TARTRATE 246 236 4 8
FUROSEMIDE 243 224 5 6
LEVOTHYROXINE SODIUM 242 230 6 3
METOPROLOL SUCCINATE 239 238 7 13
ATORVASTATIN CALCIUM 236 226 8 11
OMEPRAZOLE 219 209 9 4
ATENOLOL 182 162 10 7
JANTOVEN 171 152 11 37
WARFARIN SODIUM 169 151 12 10
HYDROCHLOROTHIAZIDE 167 162 13 9
METFORMIN HCL 144 132 14 12
LOSARTAN POTASSIUM 143 135 15 14
TRAZODONE HCL 132 130 16 25
POTASSIUM CHLORIDE 131 116 17 18
FINASTERIDE 124 122 18 89
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 117 19 28
CITALOPRAM HBR 111 88 20 17
SPIRONOLACTONE 95 91 21 48
RANITIDINE HCL 92 82 22 34
SERTRALINE HCL 86 85 23 22
DONEPEZIL HCL 82 82 24 31
GABAPENTIN 79 77 25 16
TRAMADOL HCL 78 76 26 19
HYDROCODONE-ACETAMINOPHEN 70 50 S3 27 15
CLOPIDOGREL 69 65 28 47
ISOSORBIDE MONONITRATE ER 67 56 29 36
ALFUZOSIN HCL 65 62 30 206
ZOLPIDEM TARTRATE 64 57 31 23
PREDNISONE 61 61 32 24
CARVEDILOL 59 40 33 35
FLUTICASONE PROPIONATE 55 51 34 30
ALLOPURINOL 54 48 35 26
HYDROCORTISONE 52 49 36 216
TERAZOSIN HCL 51 48 37 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.